AAAAAA

   
Results: 1-12 |
Results: 12
FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function
Authors: Lean, JM Fuller, K Chambers, TJ
Citation: Jm. Lean et al., FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function, BLOOD, 98(9), 2001, pp. 2707-2713
Osteoclast lineage commitment of bone marrow precursors through expressionof membrane-bound TRANCE
Authors: Lean, JM Matsuo, K Fox, SW Fuller, K Gibson, FM Draycott, G Wani, MR Bayley, KE Wong, BR Choi, Y Wagner, EF Chambers, TJ
Citation: Jm. Lean et al., Osteoclast lineage commitment of bone marrow precursors through expressionof membrane-bound TRANCE, BONE, 27(1), 2000, pp. 29-40
Lactose, rickets, and the coevolution of genes and culture
Authors: Fuller, K
Citation: K. Fuller, Lactose, rickets, and the coevolution of genes and culture, HUMAN ECOL, 28(3), 2000, pp. 471-477
TGF-beta(1) and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype
Authors: Fox, SW Fuller, K Bayley, KE Lean, JM Chambers, TJ
Citation: Sw. Fox et al., TGF-beta(1) and IFN-gamma direct macrophage activation by TNF-alpha to osteoclastic or cytocidal phenotype, J IMMUNOL, 165(9), 2000, pp. 4957-4963
Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro
Authors: Fox, SW Fuller, K Chambers, TJ
Citation: Sw. Fox et al., Activation of osteoclasts by interleukin-1: Divergent responsiveness in osteoclasts formed in vivo and in vitro, J CELL PHYS, 184(3), 2000, pp. 334-340
A role for TGF beta(1) in osteoclast differentiation and survival
Authors: Fuller, K Lean, JM Bayley, KE Chambers, TJ
Citation: K. Fuller et al., A role for TGF beta(1) in osteoclast differentiation and survival, J CELL SCI, 113(13), 2000, pp. 2445-2453
Activin A is an essential cofactor for osteoclast induction
Authors: Fuller, K Bayley, KE Chambers, TJ
Citation: K. Fuller et al., Activin A is an essential cofactor for osteoclast induction, BIOC BIOP R, 268(1), 2000, pp. 2-7
Prospective audit of cytomegalovirus-negative blood product utilization inhaematology/oncology patients
Authors: Chang, H Hawes, J Hall, GA Fuller, K Francombe, WH Zuber, E Sher, GD
Citation: H. Chang et al., Prospective audit of cytomegalovirus-negative blood product utilization inhaematology/oncology patients, TRANSFUS M, 9(3), 1999, pp. 195-198
Adsorption and decomposition of H2S on the Ge(100) surface
Authors: Nelen, LM Fuller, K Greenlief, CM
Citation: Lm. Nelen et al., Adsorption and decomposition of H2S on the Ge(100) surface, APPL SURF S, 150(1-4), 1999, pp. 65-72
Aberrant prostaglandin synthase 2 expression defines an antigen-presentingcell defect for insulin-dependent diabetes mellitus
Authors: Litherland, SA Xie, XT Hutson, AD Wasserfall, C Whittaker, DS She, JX Hofig, A Dennis, MA Fuller, K Cook, R Schatz, D Moldawer, LL Clare-Salzler, MJ
Citation: Sa. Litherland et al., Aberrant prostaglandin synthase 2 expression defines an antigen-presentingcell defect for insulin-dependent diabetes mellitus, J CLIN INV, 104(4), 1999, pp. 515-523
School daze
Authors: Fuller, K
Citation: K. Fuller, School daze, FORBES, 163(7), 1999, pp. 16-16
Prostaglandin E-2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading, and fusion
Authors: Wani, MR Fuller, K Kim, NS Choi, YW Chambers, T
Citation: Mr. Wani et al., Prostaglandin E-2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading, and fusion, ENDOCRINOL, 140(4), 1999, pp. 1927-1935
Risultati: 1-12 |